|
||||||||||||||
| Table 1: Observations in clinical trials conducted at AIIMS in patients of carcinoma of prostate after immunization with either 200 μg or 400 μg of anti-LHRH vaccine. Vaccine was administered as 3 primary injections at monthly interval followed by a booster at 8th month [2]. | ||||||||||||||
